Nasdaq Inc/ US6311031081 /
06/05/2024 22:00:00 | Var. +0.7300 | Volume | Denaro01:25:55 | Lettera01:25:55 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
61.6000USD | +1.20% | 2.92 mill. Fatturato: 119.85 mill. |
60.1000Quantità in denaro: 100 | 61.9900Quantità in lettera: 200 | 30.26 bill.USD | 1.40% | 29.33 |
Newsfile Corp
07:00
KaJ Labs Commits $23 Million to Build Multichain AI NFT Platform Colle AI (COLLE)
GlobeNewswire
07:00
BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Roun...
GlobeNewswire
07:00
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
05:00
INTEL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Agains...
GlobeNewswire
05:00
SUNNOVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Sunnova Energy International Inc. on Beh...
GlobeNewswire
05:00
INNODATA ALERT: Bragar Eagel & Squire, P.C. is Investigating Innodata Inc. on Behalf of Long-Term St...
GlobeNewswire
05:00
AXT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ...
GlobeNewswire
04:15
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
GlobeNewswire
03:08
ROSEN, NATIONAL TRIAL COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before Impor...
GlobeNewswire
02:50
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Evolv Technologies Holdings, Inc. f/k/a NewHold Investme...
GlobeNewswire
02:34
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...